Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Shannon, HE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 66 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rasmussen, T; Fink-Jensen, A; Sauerberg, P; Swedberg, MDB; Thomsen, C; Sheardown, MJ; Jeppesen, L; Calligaro, DO; DeLapp, NW; Whitesitt, C; Ward, JS; Shannon, HE; Bymaster, FP
      The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance

      SCHIZOPHRENIA RESEARCH
    2. Shannon, HE; Jones, CK; Li, DL; Peters, SC; Simmons, RMA; Iyengar, S
      Antihyperalgesic effects of the muscarinic receptor ligand vedaclidine in models involving central sensitization in rats

      PAIN
    3. Bymaster, FP; Carter, PA; Zhang, L; Falcone, JF; Stengel, PW; Cohen, ML; Shannon, HE; Gomeza, J; Wess, J; Felder, CC
      Investigations into the physiological role of muscarinic M-2 and M-4 muscarinic and M-4 receptor subtypes using receptor knockout mice

      LIFE SCIENCES
    4. Perry, KW; Nisenbaum, LK; George, CA; Shannon, HE; Felder, CC; Bymaster, FP
      The muscarinic agonist xanomeline increases monoamine release and immediate early gene expression in the rat prefrontal cortex

      BIOLOGICAL PSYCHIATRY
    5. Shannon, HE; Rasmussen, K; Bymaster, FP; Hart, JC; Peters, SC; Swedberg, MDB; Jeppesen, L; Sheardown, MJ; Sauerberg, P; Fink-Jensen, A
      Xanomeline, an M-1/M-4 preferring muscarinic cholinergic receptor agonist,produces antipsychotic-like activity in rats and mice

      SCHIZOPHRENIA RESEARCH
    6. Shannon, HE; Lutz, EA
      Effects of the I-1 imidazoline/alpha(2)-adrenergic receptor agonist moxonidine in comparison with clonidine in the formalin test in rats

      PAIN
    7. Womer, DE; Shannon, HE
      Reversal of pertussis toxin-induced thermal allodynia by muscarinic cholinergic agonists in mice

      NEUROPHARMACOLOGY
    8. Womer, DE; Shannon, HE
      Pharmacologic reversal of pertussis toxin-induced thermal allodynia in mice

      NEUROPHARMACOLOGY
    9. Jones, CK; Shannon, HE
      Muscarinic cholinergic modulation of prepulse inhibition of the acoustic startle reflex

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    10. Rasmussen, T; Sauerberg, P; Nielsen, EB; Swedberg, MDB; Thomsen, C; Sheardown, MJ; Jeppesen, L; Calligaro, DO; DeLapp, NW; Whitesitt, C; Ward, JS; Shannon, HE; Bymaster, FP; Fink-Jensen, A
      Muscarinic receptor agonists decrease cocaine self-administration rates indrug-naive mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    11. Jones, CK; Shannon, HE
      Effects of scopolamine in comparison with apomorphine and phencyclidine onprepulse inhibition in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    12. Brodkin, J; Shannon, HE
      Communicating synergism in drug combination studies

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    13. Shannon, HE; Lutz, EA
      Yohimbine produces antinociception in the formalin test in rats: involvement of serotonin(1A) receptors

      PSYCHOPHARMACOLOGY
    14. Sawyer, BD; Bymaster, FP; Calligaro, DO; Falcone, J; Mitch, CH; Ward, JS; Whitesitt, C; Shannon, HE
      Direct pharmacological comparison of the muscarinic receptors mediating relaxation and contraction in the rabbit thoracic aorta

      GENERAL PHARMACOLOGY
    15. Bymaster, FP; Shannon, HE; Rasmussen, K; DeLapp, NW; Ward, JS; Calligaro, DO; Mitch, CH; Whitesitt, C; Ludvigsen, TS; Sheardown, M; Swedberg, M; Rasmussen, T; Olesen, PH; Jeppesen, L; Sauerberg, P; Fink-Jensen, A
      Potential role of muscarinic receptors in schizophrenia

      LIFE SCIENCES
    16. Shannon, HE; Hart, JC; Bymaster, FP; Calligaro, DO; Delapp, NW; Mitch, CH; Ward, JS; Fink-Jensen, A; Sauerberg, P; Jeppesen, L; Sheardown, MJ; Swedberg, MDB
      Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    17. Jeppesen, L; Olesen, PH; Hansen, L; Sheardown, MJ; Thomsen, C; Rasmussen, T; Jensen, AF; Christensen, MS; Rimvall, K; Ward, JS; Whitesitt, C; Calligaro, DO; Bymaster, FP; Delapp, NW; Felder, CC; Shannon, HE; Sauerberg, P
      1-(1,2,5-thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M-1 agonists: Structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivatives

      JOURNAL OF MEDICINAL CHEMISTRY
    18. SAUERBERG P; JEPPESEN L; OLESEN PH; SHEARDOWN MJ; FINKJENSEN A; RASMUSSEN T; RIMVALL K; SHANNON HE; BYMASTER FP; DELAPP NW; CALLIGARO DO; WARD JS; WHITESITT CA; THOMSEN C
      IDENTIFICATION OF SIDE-CHAINS ON 1,2,5-THIADIAZOLE-AZACYCLES OPTIMAL FOR MUSCARINIC M1 RECEPTOR ACTIVATION

      Bioorganic & medicinal chemistry letters
    19. Fink-Jensen, A; Kristensen, P; Shannon, HE; Calligaro, DO; Delapp, NW; Whitesitt, C; Ward, JS; Thomsen, C; Rasmusseen, T; Sheardown, MJ; Jeppesen, L; Sauerberg, P; Bymaster, FP
      Muscarinic agonists exhibit functional dopamine antagonism in unilaterally6-OHDA lesioned rats

      NEUROREPORT
    20. SHANNON HE; BYMASTER FP; BODICK NW; OFFEN WW; DELAPP NC; PERRY KW; RASMUSSEN K; WARD JS; WHITESITT CA; FINKJENSEN A; OLESEN P; RASMUSSEN T; SHEARDOWN M; SWEDBERG M; SAUERBERG P
      MUSCARINIC AGENTS - A NEW APPROACH TO THE TREATMENT OF PSYCHOSIS

      Schizophrenia research
    21. JONES CK; SHANNON HE
      BILATERAL LESIONS OF THE LATERODORSAL TEGMENTAL NUCLEUS DISRUPT PREPULSE INHIBITION OF THE ACOUSTIC STARTLE REFLEX IN RATS

      Schizophrenia research
    22. WARD JS; MERRITT L; CALLIGARO DO; BYMASTER FP; SHANNON HE; MITCH CH; WHITESITT C; BRUNSTING D; SHEARDOWN MJ; OLESEN PH; SWEDBERG MDB; JEPPESEN L; SAUERBERG P
      1,2,5-THIADIAZOLE ANALOGS OF ACECLIDINE AS POTENT M(1) MUSCARINIC AGONISTS

      Journal of medicinal chemistry
    23. SAUERBERG P; JEPPESEN L; OLESEN PH; RASMUSSEN T; SWEDBERG MDB; SHEARDOWN MJ; FINKJENSEN A; THOMSEN C; THOGERSEN H; RIMVALL K; WARD JS; CALLIGARO DO; DELAPP NW; BYMASTER FP; SHANNON HE
      MUSCARINIC AGONISTS WITH ANTIPSYCHOTIC-LIKE ACTIVITY - STRUCTURE-ACTIVITY-RELATIONSHIPS OF 1,2,5-THIADIAZOLE ANALOGS WITH FUNCTIONAL DOPAMINE ANTAGONIST ACTIVITY

      Journal of medicinal chemistry
    24. SAUERBERG P; OLESEN PH; SHEARDOWN MJ; RIMVALL K; THOGERSEN H; SHANNON HE; SAWYER BD; WARD JS; BYMASTER FP; DELAPP NW; CALLIGARO DO; SWEDBERG MDB
      CONFORMATIONALLY CONSTRAINED ANALOGS OF THE MUSCARINIC AGONIST IADIAZOL-3-YL)-1,2,5,6-TETRAHYDRO-1-METHYLPYRIDINE - SYNTHESIS, RECEPTOR AFFINITY, AND ANTINOCICEPTIVE ACTIVITY

      Journal of medicinal chemistry
    25. BYMASTER FP; SHANNON HE; RASMUSSEN K; DELAPP NW; MITCH CH; WARD JS; CALLIGARO DO; LUDVIGSEN TS; SHEARDOWN MJ; OLESEN PH; SWEDBERG MDB; SAUERBERG P; FINKJENSEN A
      UNEXPECTED ANTIPSYCHOTIC-LIKE ACTIVITY WITH THE MUSCARINIC RECEPTOR-LIGAND O-1,2,5-THIADIAZOL-4-YL)-1-AZABICYCLO[3.2.1]OCTANE

      European journal of pharmacology
    26. GLEASON SD; SHANNON HE
      META-CHLOROPHENYLPIPERAZINE INDUCED CHANGES IN LOCOMOTOR-ACTIVITY AREMEDIATED BY 5-HT1 AS WELL AS 5-HT2C RECEPTORS IN MICE

      European journal of pharmacology
    27. BYMASTER FP; CARTER PA; PETERS SC; ZHANG W; WARD JS; MITCH CH; CALLIGARO DO; WHITESITT CA; DELAPP N; SHANNON HE; RIMVALL K; JEPPESEN L; SHEARDOWN MJ; FINKJENSEN A; SAUERBERG P
      XANOMELINE COMPARED TO OTHER MUSCARINIC AGENTS ON STIMULATION OF PHOSPHOINOSITIDE HYDROLYSIS IN-VIVO AND OTHER CHOLINOMIMETIC EFFECTS

      Brain research
    28. JONES CK; SHANNON HE
      A ROLE FOR MUSCARINIC CHOLINERGIC SYSTEMS IN THE MECHANISMS OF PREPULSE INHIBITION OF THE ACOUSTIC STARTLE REFLEX AND SCHIZOPHRENIA

      Schizophrenia research
    29. BODICK NC; OFFEN WW; SHANNON HE; SATTERWHITE J; LUCAS R; VANLIER R; PAUL SM
      THE SELECTIVE MUSCARINIC AGONIST XANOMELINE IMPROVES BOTH THE COGNITIVE DEFICITS AND BEHAVIORAL SYMPTOMS OF ALZHEIMER-DISEASE

      Alzheimer disease and associated disorders
    30. WOMER DE; DELAPP NW; SHANNON HE
      INTRATHECAL PERTUSSIS TOXIN PRODUCES HYPERALGESIA AND ALLODYNIA IN MICE

      Pain
    31. BYMASTER FP; WHITESITT CA; SHANNON HE; DELAPP N; WARD JS; CALLIGARO DO; SHIPLEY LA; BUELKESAM JL; BODICK NC; FARDE L; SHEARDOWN MJ; OLESEN PH; HANSEN KT; SUZDAK PD; SWEDBERG MDB; SAUERBERG P; MITCH CH
      XANOMELINE - A SELECTIVE MUSCARINIC AGONIST FOR THE TREATMENT OF ALZHEIMERS-DISEASE

      Drug development research
    32. SAUERBERG P; OLESEN PH; THOGERSEN H; NIELSEN S; SHEARDOWN MJ; RIMVALL K; SHANNON HE; WARD JS; MITCH CH; BYMASTER FP; SWEDBERG MDB
      CONFORMATIONALLY CONSTRAINED ANALOGS OF THE MUSCARINIC AGONIST METHYLTHIO-TZTP - SYNTHESIS, RECEPTOR AFFINITY AND ANALGESIC ACTIVITY

      Life sciences
    33. WARD JS; MERRITT L; STRATFORD R; BROWN TJ; WIJAYARATNE R; SZEWCZYK SP; CALLIGARO DO; BYMASTER FP; SHANNON HE; MITCH CH; JOHNSON DW; WIKEL JH; OLESEN MJ; SHEARDOWN MJ; SWEDBERG MDB; SAUERBERG P
      THE TETRAHYDROPYRIDINE RING CONFERS OPTIMAL M(1) SELECTIVITY AND BLOOD-BRAIN-BARRIER PENETRATION AMONG HEXYLOXY-1,2,5-THIADIAZOLE AZACYCLES

      Life sciences
    34. DELAPP NW; WOMER DE; SHANNON HE
      AN IMMUNOBLOT ASSAY FOR PTX ADP-RIBOSYLATION OF BRAIN AND SPINAL-CORDGI 0 PROTEINS/

      Life sciences
    35. JONES CK; SHANNON HE
      THE EFFECTS OF MUSCARINIC CHOLINERGIC ANTAGONISTS AND AGONISTS ON PREPULSE INHIBITION OF THE ACOUSTIC STARTLE REFLEX

      Life sciences
    36. SHANNON HE; WOMER DE; DELAPP NW; BYMASTER FP; MITCH CH; WARD JS; WHITESITT C; CALLIGARO D; SWEDBERG MDB; SHEARDOWN MJ; SAUERBERG P; RIMVALL K; FINKJENSEN A; JEPPESEN L
      MUSCARINIC AGONISTS PRODUCE ANALGESIA THROUGH PERTUSSIS-TOXIN-SENSITIVE MUSCARINIC RECEPTORS IN THE SPINAL-CORD

      Life sciences
    37. SWEDBERG MDB; SHANNON HE; SHEARDOWN MJ; KLITGAARD H; BYMASTER FP; WARD JS; MITCH CH; OLESEN PH; ESKESEN K; SUZDAK PD; CALLIGARO DO; SAUERBERG P
      ANTICONVULSANT EFFECTS OF MUSCARINICS

      Life sciences
    38. SHANNON HE; WOMER DE; BYMASTER FP; CALLIGARO DO; DELAPP NC; MITCH CH; WARD JS; WHITESITT CA; SWEDBERG MDB; SHEARDOWN MJ; FINKJENSEN A; OLESEN PH; RIMVALL K; SAUERBERG P
      IN-VIVO PHARMACOLOGY OF BUTYLTHIO[2.2.2] (LY297802 NNC11-1053), AN ORALLY ACTING ANTINOCICEPTIVE MUSCARINIC AGONIST/

      Life sciences
    39. SHEARDOWN MJ; SHANNON HE; SWEDBERG MDB; SUZDAK PD; BYMASTER FP; OLESEN PH; MITCH CH; WARD JS; SAUERBERG P
      M-1 RECEPTOR AGONIST ACTIVITY IS NOT A REQUIREMENT FOR MUSCARINIC ANTINOCICEPTION

      The Journal of pharmacology and experimental therapeutics
    40. SWEDBERG MDB; SHEARDOWN MJ; SAUERBERG P; OLESEN PH; SUZDAK PD; HANSEN KT; BYMASTER FP; WARD JS; MITCH CH; CALLIGARO DO; DELAPP NW; SHANNON HE
      BUTYLTHIO[2.2.2] (NNC 11-1053 LY297802) - AN ORALLY-ACTIVE MUSCARINICAGONIST ANALGESIC/

      The Journal of pharmacology and experimental therapeutics
    41. SHANNON HE; SHEARDOWN MJ; BYMASTER FP; CALLIGARO DO; DELAPP NW; GIDDA J; MITCH CH; SAWYER BD; STENGEL PW; WARD JS; WONG DT; OLESEN PH; SUZDAK PD; SAUERBERG P; SWEDBERG MDB
      PHARMACOLOGY OF BUTYLTHIO[2.2.2] (LY297802 NNC11-1053) - A NOVEL ANALGESIC WITH MIXED MUSCARINIC RECEPTOR AGONIST AND ANTAGONIST ACTIVITY/

      The Journal of pharmacology and experimental therapeutics
    42. MITCH CH; BROWN TJ; BYMASTER FP; CALLIGARO DO; DIECKMAN D; MERRIT L; PETERS SC; QUIMBY SJ; SHANNON HE; SHIPLEY LA; WARD JS; HANSEN K; OLESEN PH; SAUERBERG P; SHEARDOWN MJ; SWEDBERG MDB; SUZDAK P; GREENWOOD B
      MUSCARINIC ANALGESICS WITH POTENT AND SELECTIVE EFFECTS ON THE GASTROINTESTINAL-TRACT - POTENTIAL APPLICATION FOR THE TREATMENT OF IRRITABLE-BOWEL-SYNDROME

      Journal of medicinal chemistry
    43. BODICK NC; OFFEN WW; LEVEY AI; CUTLER NR; GAUTHIER SG; SATLIN A; SHANNON HE; TOLLEFSON GD; RASMUSSEN K; BYMASTER FP; HURLEY DJ; POTTER WZ; PAUL SM
      EFFECTS OF XANOMELINE, A SELECTIVE MUSCARINIC RECEPTOR AGONIST, ON COGNITIVE FUNCTION AND BEHAVIORAL SYMPTOMS IN ALZHEIMER-DISEASE

      Archives of neurology
    44. GLEASON SD; SHANNON HE
      BLOCKADE OF PHENCYCLIDINE-INDUCED HYPERLOCOMOTION BY OLANZAPINE, CLOZAPINE AND SEROTONIN RECEPTOR SUBTYPE-SELECTIVE ANTAGONISTS IN MICE

      Psychopharmacology
    45. FARDE L; SUHARA T; HALLDIN C; NYBACK H; NAKASHIMA Y; SWAHN CG; KARLSSON P; GINOVART N; BYMASTER FP; SHANNON HE; FOGED C; SUZDAK PD; SAUERBERG P
      PET STUDY OF THE M(1)-AGONISTS [C-11] XANOMELINE AND [C-11] BUTYLTHIO-TZTP IN MONKEY AND MAN

      Dementia
    46. OLESEN PH; SAUERBERG P; TREPPENDAHL S; LARSSON O; SHEARDOWN MJ; SUZDAK PD; MITCH CH; WARD JS; BYMASTER FP; SHANNON HE; SWEDBERG MDB
      3-(3-ALKYLTHIO-1,2,5-THIADIAZOL-4-YL)1-AZABICYCLE - STRUCTURE-ACTIVITY-RELATIONSHIPS FOR ANTINOCICEPTION MEDIATED BY CENTRAL MUSCARINIC RECEPTORS

      European journal of medicinal chemistry
    47. DELAPP NW; ECKOLS K; SHANNON HE
      MUSCARINIC AGONIST INHIBITION OF RAT STRIATAL ADENYLATE-CYCLASE IS ENHANCED BY DOPAMINE STIMULATION

      Life sciences
    48. KROPP BP; SAWYER BD; SHANNON HE; RIPPY MK; BADYLAK SF; ADAMS MC; KEATING MA; RINK RC; THOR KB
      CHARACTERIZATION OF SMALL-INTESTINAL SUBMUCOSA REGENERATED CANINE DETRUSOR - ASSESSMENT OF REINNERVATION, IN-VITRO COMPLIANCE AND CONTRACTILITY

      The Journal of urology
    49. VAUGHT JD; KROPP BP; SAWYER BD; RIPPY MK; BADYLAK SF; SHANNON HE; THOR KB
      DETRUSOR REGENERATION IN THE RAT USING PORCINE SMALL-INTESTINAL SUBMUCOSAL GRAFTS - FUNCTIONAL INNERVATION AND RECEPTOR EXPRESSION

      The Journal of urology
    50. ECKOLS K; BYMASTER FP; MITCH CH; SHANNON HE; WARD JS; DELAPP NW
      THE MUSCARINIC M1 AGONIST XANOMELINE INCREASES SOLUBLE AMYLOID PRECURSOR PROTEIN RELEASE FROM CHINESE-HAMSTER OVARY-M1 CELLS

      Life sciences
    51. SAUERBERG P; OLESEN PH; SHEARDOWN MJ; SUZDAK PD; SHANNON HE; BYMASTER FP; CALLIGARO DO; MITCH CH; WARD JS; SWEDBERG MDB
      MUSCARINIC AGONISTS AS ANALGESICS - ANTINOCICEPTIVE ACTIVITY VERSUS M(1) ACTIVITY - SAR OF ALKYLTHIO-TZTPS AND RELATED 1,2,5-THIADIAZOLE ANALOGS

      Life sciences
    52. WARD JS; MERRITT L; CALLIGARO DO; BYMASTER FP; SHANNON HE; SAWYER BD; MITCH CH; SHEARDOWN MJ; OLESEN PH; SUZDAK PD; SWEDBERG MDB
      3-(3-HEXYLOXYPYRAZINYL) QUINUCLIDINE AS A FUNCTIONALLY SELECTIVE M(1)AGONIST

      Life sciences
    53. SAWYER BD; SHANNON HE; WARD JS; MITCH CH; SHEARDOWN MJ; OLESEN PH; SAUERBERG P
      MUSCARINIC RECEPTOR CHARACTERIZATION AND EVALUATION OF A SERIES OF NOVEL MUSCARINIC LIGANDS IN THE ISOLATED RABBIT THORACIC AORTA

      Life sciences
    54. MITCH CH; BYMASTER FP; CALLIGARO DO; QUIMBY SJ; SAWYER BD; WARD JS; OLESEN PH; SAUERBERG P; SHEARDOWN MJ; SUZDAK PD; SWEDBERG M; SHANNON HE
      SIDE-CHAIN STERIC BULK AND MUSCARINIC AGONIST SAR IN ALKOXY-TZTPS

      Life sciences
    55. BYMASTER FP; FALCONE JF; SHANNON HE; CALLIGARO DO
      ARACHIDONIC-ACID RELEASE BY MUSCARINIC AGENTS IN CELL-LINES TRANSFECTED WITH MUSCARINIC RECEPTORS

      Life sciences
    56. DELAPP NW; ECKOLS K; BYMASTER FP; MITCH CH; SHANNON HE; WARD JS
      THE M1 AGONIST XANOMELINE POTENTLY STIMULATES APPS RELEASE FROM CHO-M1 CELLS

      Life sciences
    57. SHANNON HE; BYMASTER FP; CALLIGARO DO; MITCH CH; SAWYER BD; WARD JS; SHEARDOWN MJ; OLESEN PH; SAUERBERG P; SUZDAK PD; SWEDBERG MDB
      IN-VITRO PHARMACOLOGY OF THE MUSCARINIC ANALGESIC LY297802 NNC111053/

      Life sciences
    58. SWEDBERG MDB; SHEARDOWN MJ; SAUERBERG P; OLESEN P; SUZDAK PD; BYMASTER FP; WARD JS; MITCH CH; CALLIGARO DO; SHANNON HE
      NNC-11-1053 LY-297802 - AN ANTINOCICEPTIVE ORALLY ACTING MUSCARINIC AGONIST IN MOUSE AND RAT

      Life sciences
    59. WARD JS; MERRITT L; CALLIGARO DO; BYMASTER FP; SHANNON HE; SAWYER BD; MITCH CH; DEETER JB; PETERS SC; SHEARDOWN MJ; OLESEN PH; SWEDBERG MDB; SAUERBERG P
      FUNCTIONALLY SELECTIVE M(1) MUSCARINIC AGONISTS .3. SIDE-CHAINS AND AZACYCLES CONTRIBUTING TO FUNCTIONAL MUSCARINIC SELECTIVITY AMONG PYRAZINYLAZACYCLES

      Journal of medicinal chemistry
    60. SHANNON HE; BYMASTER FP; HENDRIX JC; QUIMBY SJ; MITCH CH
      NOVEL ALKOXY-OXAZOLYL-TETRAHYDROPYRIDINE MUSCARINIC CHOLINERGIC RECEPTOR ANTAGONISTS

      Psychopharmacology
    61. QUIMBY SJ; SHANNON HE; BYMASTER FP; SAUERBERG P; OLESEN PH; SHEARDOWN MJ; SUZDAK PD; MITCH CH
      SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF ALKYL SUBSTITUTED ANALOGS OF THE FUNCTIONAL M(1) SELECTIVE MUSCARINIC RECEPTOR AGONIST XANOMELINE

      Bioorganic & medicinal chemistry letters
    62. MITCH CH; BYMASTER FP; CALLIGARO DO; QUIMBY SJ; SCHOEPP DD; WONG DT; SHANNON HE
      MUSCARINIC ANTAGONIST ACTIVITY OF (5-ALKOXY-OXAZOL-2-YL)-1,2,5,6-TETRAHYDROPYRIDINES

      Bioorganic & medicinal chemistry letters
    63. MITCH CH; BYMASTER FP; CALLIGARO DO; QUIMBY SJ; SAWYER BD; SHANNON HE; WARD JS; OLESEN PH; SAUERBERG P; SHEARDOWN MJ; SUZDAK PD
      XANOMELINE - A POTENT AND SELECTIVE M1 MUSCARINIC AGONIST IN-VITRO

      Neurobiology of aging
    64. SHANNON HE; BYMASTER FP; CALLIGARO DO; GREENWOOD B; MITCH CH; SAWYER BD; WARD JS; WONG DT; OLESEN PH; SHEARDOWN MJ; SWEDBERG MDB; SUZDAK PD; SAUERBERG P
      XANOMELINE - A NOVEL MUSCARINIC RECEPTOR AGONIST WITH FUNCTIONAL SELECTIVITY FOR M(1) RECEPTORS

      The Journal of pharmacology and experimental therapeutics
    65. BYMASTER FP; WONG DT; MITCH CH; WARD JS; CALLIGARO DO; SCHOEPP DD; SHANNON HE; SHEARDOWN MJ; OLESEN PH; SUZDAK PD; SWEDBERG MDB; SAUERBERG P
      NEUROCHEMICAL EFFECTS OF THE M(1) MUSCARINIC AGONIST XANOMELINE (LY246708 NNC11-0232)/

      The Journal of pharmacology and experimental therapeutics
    66. BYMASTER FP; HEATH I; HENDRIX JC; SHANNON HE
      COMPARATIVE BEHAVIORAL AND NEUROCHEMICAL ACTIVITIES OF CHOLINERGIC ANTAGONISTS IN RATS

      The Journal of pharmacology and experimental therapeutics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/02/20 alle ore 20:36:26